Form 4: Edwards Lifesciences SVP, Corporate Controller Reports Changes in Beneficial Ownership

Robert W.A. Sellers, SVP, Corporate Controller at Edwards Lifesciences, reports acquisition and disposal of common stock and stock options.

Summary

• On May 7, 2024, Robert W.A. Sellers, SVP, Corporate Controller of Edwards Lifesciences Corp, reported changes in beneficial ownership.
• Sellers acquired 2,445 shares of common stock at $0.00 and disposed of 178 shares at $85.09.
• Following these transactions, Sellers directly owns 17,310.198 shares of common stock and indirectly owns 20,409 shares through a trust.
• Sellers was also granted 4,820 employee stock options with an exercise price of $85.84, vesting monthly starting June 7, 2024, and expiring on May 6, 2031.
• Additionally, 2,445 restricted stock units were granted, vesting annually starting May 7, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to executive compensation. There is no indication of unusual or concerning activity.

Positives

• The grant of restricted stock units and employee stock options to a key executive suggests a continued investment in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are a common form of executive compensation in the biotechnology and medical device industries.
• Companies like Medtronic and Abbott also utilize similar equity-based compensation plans to align executive interests with shareholder value.
• The vesting schedules and exercise prices are generally in line with industry norms for long-term incentive programs.

Stakeholder Impact

• The transactions reported may have a minor impact on shareholders by slightly diluting the value of existing shares.
• The equity grants incentivize the executive to work towards the long-term success of the company, which benefits all stakeholders.

Key Dates